We are live on ! Find out more
AIM

Alerce Investment Management Portfolio holdings

AUM $56.8M
1-Year Est. Return 31.17%
This Fund
S&P 500
This Quarter Est. Return
-17.03%
1 Year Est. Return
+31.17%
3 Year Est. Return
+25.12%
5 Year Est. Return
10 Year Est. Return
AUM
$254M
AUM Growth
Cap. Flow
+$292M
Cap. Flow %
114.93%
Top 10 Hldgs %
100%
Holding
7
New
7
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMWL icon
1
American Well
AMWL
$180M
$160M 62.85%
+315,039
New +$182M
ANNX icon
2
Annexon
ANNX
$834M
$48.9M 19.27%
+1,954,978
New +$50.3M
ASMB icon
3
Assembly Biosciences
ASMB
$498M
$13.5M 5.31%
+185,625
New +$21.8M
AKBA icon
4
Akebia Therapeutics
AKBA
$354M
$13M 5.13%
+4,652,561
New +$13.6M
RNTX
5
Rein Therapeutics
RNTX
$63.1M
$7.91M 3.12%
+380,472
New +$9.51M
WHWK
6
Whitehawk Therapeutics
WHWK
$190M
$5.51M 2.17%
+374,789
New +$8.01M
GBT
7
DELISTED
Global Blood Therapeutics, Inc.
GBT
$5.47M 2.15%
+126,270
New +$6.23M

Similar funds

Alerce Investment Management's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Alerce Investment Management, which disclosed 7 positions worth $254M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is American Well: 315,039 shares worth $160M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Alerce Investment Management's largest Q4 2020 buy was American Well: 315,039 shares worth $160M.
  • Alerce Investment Management's ten largest holdings make up 100% of its $254M portfolio in Q4 2020.
  • Alerce Investment Management disclosed 7 positions in Q4 2020, its first 13F filing on record.

Based on Alerce Investment Management's 13F filing for Q4 2020, filed 11 Feb 2021.